Evaluation of the Hologic Panther Fusion investigational use only assays for gastrointestinal bacterial pathogens
Bacterial causes of diarrhea lead to significant morbidity and mortality around the world. Historic testing methods, for example, antigens and culture. For these reasons, molecular testing for enteric bacterial pathogens has become widely used, but there are limited numbers of commercially available tests on the market, especially those suitable for higher-throughput testing. We show that the high-throughput, random- access investigational use only Hologic Panther Fusion Gastrointestinal (GI) Bacterial assay and Panther Fusion GI Expanded Bacterial assay perform comparably to existing assays.
Authors
- Jacob Merwede
- Rama Yakubu (ORCID: https://orcid.org/0000-0003-0298-6734)
- Vikas Patel (ORCID: https://orcid.org/0000-0002-6325-4572)
- David R. Peaper (ORCID: https://orcid.org/0000-0002-9952-5012)
- Brianna Viglione
Institutions
- Yale New Haven Hospital (US)
- Yale University (US)
Publication Details
- Journal
- Journal of Clinical Microbiology
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1128/jcm.00730-25
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 0.00